GlassScriptPhysician profile
Deborah L Reich
NPI 1609807528
$1,571.15
in general payments reported to CMS, 2019-2025
15 companies · $27.38 in 2025
The $27.38 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $293 · 2021: $289 · 2022: $201 · 2023: $217 · 2024: $273 · 2025: $27.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $517.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $566.60 | 2019-2023 | Lybalvi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $195.12 | 2022-2024 | Relistor |
| Gilead Sciences, INC. | $190.17 | 2019-2020 | |
| Abbvie INC. | $180.17 | 2023-2024 | |
| Redhill Biopharma INC. | $91.66 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $87.28 | 2020-2021 | |
| Grt US Holding, INC. | $55.30 | 2022 | |
| Biodelivery Sciences International, INC. | $40.05 | 2019-2021 | |
| Lundbeck LLC | $33.02 | 2024 | Vyepti |
| Rayner Intraocular Lenses Limited | $27.38 | 2025 | Omidria |
| Amgen INC. | $25.27 | 2021 | |
| Medtronic USA, INC. | $23.54 | 2020 | |
| Scilex Pharmaceuticals INC. | $21.64 | 2020 | |
| Jazz Pharmaceuticals INC. | $20.40 | 2021 | |
| Shionogi INC | $13.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Reich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.